Cytomegalovirus (CMV) is the most common viral infection after solid organ transplantation. Great innovations have been achieved in terms of CMV screening, antiviral prophylaxis and antiviral treatment. This study shows short term (1 year post-transplantation) and long term (10 years post-transplantation) outcomes of CMV infection/disease after kidney transplantation.